about
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersGenes Regulating Epithelial Polarity Are Critical Suppressors of Esophageal OncogenesisNeoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatmentIdentification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxelAberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma.Epigenetics in the Pathogenesis of Esophageal AdenocarcinomaEvaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's EsophagusAssociation between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis.5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1.Accumulated promoter methylation as a potential biomarker for esophageal cancer.Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression.The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinomaSelective inhibition of esophageal cancer cells by combination of HDAC inhibitors and AzacytidineFOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.Sponge Sampling with Fluorescent In Situ Hybridization as a Screening Tool for the Early Detection of Esophageal Cancer.The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.KLF4 is downregulated but not mutated during human esophageal squamous cell carcinogenesis and has tumor stage-specific functions.DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma.UHRF1 is an Independent Prognostic Factor and a Potential Therapeutic Target of Esophageal Squamous Cell Carcinoma.EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma.Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma.Translational research on Barrett's esophagus.ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.Coping with esophageal cancer approaches worldwide
P2860
Q26751068-7F263B84-EB65-4A29-A4AC-4382D12192CCQ26799650-FA0F380A-ACB3-4BA2-AC03-FEF8DF7986B0Q28086781-66D47B73-1C89-4BC2-9CC2-7DAB16780891Q33933511-3F872127-6498-43C6-A65A-8FBA3BF3308FQ35184495-43DD9318-33AA-4A07-AB23-7215310B1B48Q35236801-B0D09991-2434-4695-B1A1-3C79FB1DE245Q35598456-60D91FB8-A1E6-414A-8024-6E86C33AEBACQ35792782-A7BC4430-423D-415D-8F5C-2168903F9F16Q36014804-017B09C9-9C47-47C7-8CCF-154D6E49E4D4Q37118354-A4AD989F-FCAE-42F6-9A0E-6AD828BA2E78Q37269937-3C105A95-3DE9-4C42-8961-9337DCB9C39CQ37702338-181C5A67-DC01-4B14-B451-3EB78F752378Q38093059-81B42F83-A91A-4769-827C-ADA838C98E8FQ38212001-6EF78107-28FE-4FF2-82D9-77ACD1732569Q38712855-B00523ED-B509-4696-B197-70CB9501B6A2Q38881033-670B5D71-F29C-44E2-9681-E18F2E78EA09Q38949791-39F2016C-C49D-4238-A410-043A13E2F487Q38971389-B5D8C8E7-B3CC-41F6-8B3F-D28960E91E60Q39453621-F9DB6CB1-690B-4CE4-911F-EC00A3DBD654Q40341808-0A3C7F78-72FD-41AE-BE24-DD52D0F88292Q42316699-9D16CB6F-FE0A-4CFA-BAAA-F68B5A65FB2EQ42688550-2F9A84CB-5FA3-4E41-A879-9476E29DFBFFQ47121817-0FBFD775-D97B-4D09-83CC-676B1E2675CEQ47301297-B5DD9FDE-5068-458D-A20A-05FB763CEACEQ52724780-D9A1EF01-6F0D-4209-9E31-C757883A6409Q53132551-DB915E13-7F57-4136-9ACC-14EDF597BBAFQ54318784-210E3C9A-7E52-4499-8268-F02BA9624DF1Q55000594-2F23A2D2-E090-48B4-8346-8BCC02233961Q55100603-77BE4FB5-4A9B-472D-BF97-916CAC689423Q58298598-59A0198A-C94F-45CD-A31B-89A90D9B85CD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic biomarkers in esophageal cancer.
@en
Epigenetic biomarkers in esophageal cancer.
@nl
type
label
Epigenetic biomarkers in esophageal cancer.
@en
Epigenetic biomarkers in esophageal cancer.
@nl
prefLabel
Epigenetic biomarkers in esophageal cancer.
@en
Epigenetic biomarkers in esophageal cancer.
@nl
P2860
P1433
P1476
Epigenetic biomarkers in esophageal cancer.
@en
P2093
Andrew M Kaz
William M Grady
P2860
P304
P356
10.1016/J.CANLET.2012.02.036
P407
P577
2012-03-07T00:00:00Z